Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 16;23(24):e202200520.
doi: 10.1002/cbic.202200520. Epub 2022 Nov 22.

Inverse In Vitro Selection Enables Comprehensive Analysis of Cross-Chiral L-Aptamer Interactions

Alexander T Piwko  1   2 , Xuan Han  1 , Adam M Kabza  1   3 , Sougata Dey  1 , Jonathan T Sczepanski  1
Affiliations

Inverse In Vitro Selection Enables Comprehensive Analysis of Cross-Chiral L-Aptamer Interactions

Alexander T Piwko et al. Chembiochem. .

Abstract

Aptamers composed of mirror-image L-(deoxy)ribose nucleic acids, referred to as L-aptamers, are a promising class of RNA-binding reagents. Yet, the selectivity of cross-chiral interactions between L-aptamers and their RNA targets remain poorly characterized, limiting the potential utility of this approach for applications in biological systems. Herein, we carried out the first comprehensive analysis of cross-chiral L-aptamer selectivity using a newly developed "inverse" in vitro selection approach that exploits the genetic nature of the D-RNA ligand. By employing a library of more than a million target-derived sequences, we determined the RNA sequence and structural preference of a model L-aptamer and revealed previously unidentified and potentially broad off-target RNA binding behaviors. These results provide valuable information for assessing the likelihood and consequences of potential off-target interactions and reveal strategies to mitigate these effects. Thus, inverse in vitro selection provides several opportunities to advance L-aptamer technology.

Keywords: In vitro selection; L-aptamers; RNA; selectivity; sequencing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic representation of the inverse in vitro selection method and comparison to a standard selection approach. During inverse in vitro selection, the unhybridized loop domain of the RNA target, not the L-aptamer, undergoes selective enrichment to identify potential off-target sequences.
Figure 2.
Figure 2.
Sequences and secondary structures of L-6-4t, D-TAR RNA, and library D-L6N. The boxed nucleotides in D-TAR indicate the L-6-4t binding site and were randomized to generate D-L6N. Sequences of all oligonucleotides are listed in Table S1.
Figure 3.
Figure 3.
Saturation plots for binding of L-6-4t to D-TAR and D-TARUG. For simplicity, only the sequences of the 6-nt loop domain of the D-TAR hairpin is shown (boxed). The Kd is indicated in parenthesis. Data are mean ± S.D. (n = 3). Representative EMSA gels are depicted in Figures S3 and S6a.
Figure 4.
Figure 4.
(a) Sequence and secondary structure of the D-L10N library. (b) Sequence logo depicting the relative frequency of nucleotides at each position within the random domain of D-L10N following 3-rounds of inverse selection (n = 70 sequences). (c) Saturation plots for binding of L-6-4t to D-10UU, D-10CC, and D-14. For simplicity, only the sequences of loop domain of the hairpin are shown (boxed). The Kd is indicated in parenthesis. Data are mean ± S.D. (n = 3). Representative EMSA gels are depicted in Figure S5.
See this image and copyright information in PMC

References

    1. Ganser LR, Kelly ML, Herschlag D, Al-Hashimi HM, Nat. Rev. Mol. Cell Biol 2019, 20, 474–489. - PMC - PubMed
    1. Wan Y, Kertesz M, Spitale RC, Segal E, Chang HY, Nat. Rev. Genet 2011, 12, 641–655. - PMC - PubMed
    1. Bernat V, Disney MD, Neuron 2015, 87, 28–46; - PMC - PubMed
    2. Croce CM, Nat. Rev. Genet 2009, 10, 704–714; - PMC - PubMed
    3. Jaafar ZA, Kieft JS, Nat. Rev. Microbiol 2019, 17, 110–123. - PMC - PubMed
    1. Falese JP, Donlic A, Hargrove AE, Chem. Soc. Rev 2021, 50, 2224–2243; - PMC - PubMed
    2. Sheridan C, Nat. Biotechnol 2021, 39, 6–8; - PubMed
    3. Costales MG, Childs-Disney JL, Haniff HS, Disney MD, J. Med. Chem 2020, 63, 8880–8900. - PMC - PubMed
    1. Guan L, Disney MD, ACS Chem. Biol 2012, 7, 73–86; - PubMed
    2. Shortridge MD, Varani G, Curr. Opin. Struct. Biol 2015, 30, 79–88; - PMC - PubMed
    3. Thomas JR, Hergenrother PJ, Chem. Rev 2008, 108, 1171–1224; - PubMed
    4. Velagapudi SP, Gallo SM, Disney MD, Nat. Chem. Biol 2014, 10, 292–297; - PMC - PubMed
    5. Pal S, ‘t Hart P, Front. Mol. Biosci 2022, 9; - PMC - PubMed
    6. Chen Y, Yang F, Zubovic L, Pavelitz T, Yang W, Godin K, Walker M, Zheng S, Macchi P, Varani G, Nat. Chem. Biol 2016, 12, 717–723; - PMC - PubMed
    7. Koirala D, Lewicka A, Koldobskaya Y, Huang H, Piccirilli JA, ACS Chem. Biol 2020, 15, 205–216. - PMC - PubMed

Publication types

LinkOut - more resources